Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€18.80

€18.80

-2.590%
-0.5
-2.590%
-
 
06.08.26 / Stuttgart Stock Exchange WKN: 935168 / Name: ResMed / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Resmed Inc. CUFS Stock

We can see a decrease in the price for Resmed Inc. CUFS. Compared to yesterday it has lost -€0.500 (-2.590%).

Pros and Cons of Resmed Inc. CUFS in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

News

ResMed Q4 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
ResMed Q4 Earnings Call Highlights

Key Points

3 Reasons Not to Sleep on ResMed StockPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
3 Reasons Not to Sleep on ResMed Stock

I confess: I've been sleeping on ResMed (NYSE: RMD) stock, not paying much attention to it at all. But maybe I shouldn't ignore it -- and you may not want to, either.

Here are three reasons why it's